Published in J Clin Invest on January 15, 1997
Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab (2007) 3.02
Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci U S A (2007) 2.59
Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors. J Clin Invest (2005) 1.56
Activation of human medial prefrontal cortex during autonomic responses to hypoglycemia. Proc Natl Acad Sci U S A (2004) 1.54
Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology (2010) 1.53
Opioid receptor blockade improves hypoglycemia-associated autonomic failure in type 1 diabetes mellitus. J Clin Endocrinol Metab (2011) 1.52
Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure. Diabetes (2007) 1.43
Relationship among brain and blood glucose levels and spontaneous and glucoprivic feeding. J Neurosci (2009) 1.39
Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes. Diabetes Care (2011) 1.38
Bringing light to the dark side of insulin: a journey across the blood-brain barrier. Diabetes (2008) 1.30
Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation. J Clin Invest (2006) 1.30
Sensing the fuels: glucose and lipid signaling in the CNS controlling energy homeostasis. Cell Mol Life Sci (2010) 1.27
Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation. Front Neuroendocrinol (2009) 1.25
Glucose sensing neurons in the ventromedial hypothalamus. Sensors (Basel) (2010) 1.21
Effect of acute and recurrent hypoglycemia on changes in brain glycogen concentration. Endocrinology (2008) 1.18
Multiple hypothalamic circuits sense and regulate glucose levels. Am J Physiol Regul Integr Comp Physiol (2010) 1.13
Neuroendocrine responses to hypoglycemia. Ann N Y Acad Sci (2010) 1.10
Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemia. Am J Physiol Endocrinol Metab (2010) 1.06
Minireview: The value of looking backward: the essential role of the hindbrain in counterregulatory responses to glucose deficit. Endocrinology (2011) 1.06
Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis. Compr Physiol (2012) 1.01
Hypothalamic glucose sensing: making ends meet. Front Syst Neurosci (2014) 1.01
Increased GABAergic output in the ventromedial hypothalamus contributes to impaired hypoglycemic counterregulation in diabetic rats. Diabetes (2011) 1.00
Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation. Diabetes (2009) 1.00
Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of metabolic reprogramming in counterregulatory failure. Diabetes (2010) 0.96
Revisiting the Ventral Medial Nucleus of the Hypothalamus: The Roles of SF-1 Neurons in Energy Homeostasis. Front Neurosci (2013) 0.96
Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments. Endocrinol Metab Clin North Am (2012) 0.93
Effects of leptin on rat ventromedial hypothalamic neurons. Endocrinology (2008) 0.93
Hypothalamic nitric oxide in hypoglycemia detection and counterregulation: a two-edged sword. Antioxid Redox Signal (2010) 0.92
The medial amygdalar nucleus: a novel glucose-sensing region that modulates the counterregulatory response to hypoglycemia. Diabetes (2010) 0.92
Influence of VMH fuel sensing on hypoglycemic responses. Trends Endocrinol Metab (2013) 0.91
Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes. Am J Physiol Regul Integr Comp Physiol (2009) 0.90
Food restriction alters neuronal morphology in the hypothalamic ventromedial nucleus of male rats. Endocrinology (2007) 0.89
Effects of maternal genotype and diet on offspring glucose and fatty acid-sensing ventromedial hypothalamic nucleus neurons. Am J Physiol Regul Integr Comp Physiol (2009) 0.89
Control of hepatic glucose metabolism by islet and brain. Diabetes Obes Metab (2014) 0.87
Perifornical hypothalamic orexin and serotonin modulate the counterregulatory response to hypoglycemic and glucoprivic stimuli. Diabetes (2014) 0.87
Brain glucosamine boosts protective glucoprivic feeding. Endocrinology (2010) 0.86
Evidence for central regulation of glucose metabolism. J Biol Chem (2013) 0.85
The physiology of glucagon. J Diabetes Sci Technol (2010) 0.84
Glucose sensing during hypoglycemia: lessons from the lab. Diabetes Care (2009) 0.84
EphA5-EphrinA5 interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local glutamine/glutamate balance during hypoglycemia. Diabetes (2012) 0.84
Molecular pathophysiology of hepatic glucose production. Mol Aspects Med (2015) 0.84
Reduction in SGLT1 mRNA Expression in the Ventromedial Hypothalamus Improves the Counterregulatory Responses to Hypoglycemia in Recurrently Hypoglycemic and Diabetic Rats. Diabetes (2015) 0.83
The rate of fall of blood glucose determines the necessity of forebrain-projecting catecholaminergic neurons for male rat sympathoadrenal responses. Diabetes (2014) 0.83
Brain glucose sensing, glucokinase and neural control of metabolism and islet function. Diabetes Obes Metab (2014) 0.82
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. Diabetes (2008) 0.82
Sex-dependent changes in metabolism and behavior, as well as reduced anxiety after eliminating ventromedial hypothalamus excitatory output. Mol Metab (2015) 0.81
The rate-limiting step for glucose transport into the hypothalamus is across the blood-hypothalamus interface. J Neurochem (2009) 0.81
Rate of fall in blood glucose and recurrent hypoglycemia affect glucose dynamics and noradrenergic activation in the ventromedial hypothalamus. Am J Physiol Regul Integr Comp Physiol (2011) 0.81
Interleukin-6 amplifies glucagon secretion: coordinated control via the brain and pancreas. Am J Physiol Endocrinol Metab (2014) 0.81
Peripheral and central glucose sensing in hypoglycemic detection. Physiology (Bethesda) (2014) 0.81
Low-carbohydrate diets cause obesity, low-carbohydrate diets reverse obesity: a metabolic mechanism resolving the paradox. Appetite (2006) 0.81
Antecedent hindbrain glucoprivation does not impair the counterregulatory response to hypoglycemia. Diabetes (2007) 0.80
Brain insulin infusion does not augment the counterregulatory response to hypoglycemia or glucoprivation. Metabolism (2009) 0.80
Amplified hormonal counterregulatory responses to hypoglycemia in rats after systemic delivery of a SUR-1-selective K(+) channel opener? Diabetes (2008) 0.80
The neuroenergetics of stress hormones in the hippocampus and implications for memory. Front Neurosci (2015) 0.80
Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism. Exp Mol Med (2016) 0.80
The nutritional induction of COUP-TFII gene expression in ventromedial hypothalamic neurons is mediated by the melanocortin pathway. PLoS One (2010) 0.80
Functional identification of a neurocircuit regulating blood glucose. Proc Natl Acad Sci U S A (2016) 0.79
Mechanisms of the blunting of the sympatho-adrenal response: a theory. Curr Diabetes Rev (2009) 0.79
Recurrent hypoglycemia increases hypothalamic glucose phosphorylation activity in rats. Metabolism (2010) 0.79
Role of the hypothalamus in mediating protective effects of dietary restriction during aging. Front Neuroendocrinol (2012) 0.79
Regulation of peripheral metabolism by substrate partitioning in the brain. Endocrinol Metab Clin North Am (2013) 0.79
BAD modulates counterregulatory responses to hypoglycemia and protective glucoprivic feeding. PLoS One (2011) 0.79
Is there cross talk between portal and hypothalamic glucose-sensing circuits? Diabetes (2014) 0.78
Refeeding-induced brown adipose tissue glycogen hyper-accumulation in mice is mediated by insulin and catecholamines. PLoS One (2013) 0.78
β2-Adrenergic receptor agonist administration promotes counter-regulatory responses and recovery from hypoglycaemia in rats. Diabetologia (2013) 0.78
Initial experience with seven tesla magnetic resonance spectroscopy of hypothalamic GABA during hyperinsulinemic euglycemia and hypoglycemia in healthy humans. Magn Reson Med (2013) 0.78
2. Hypoglycemia Detection. Transl Endocrinol Metab (2012) 0.78
Hypothalamic S-nitrosylation contributes to the counter-regulatory response impairment following recurrent hypoglycemia. PLoS One (2013) 0.77
Estrogens modulate ventrolateral ventromedial hypothalamic glucose-inhibited neurons. Mol Metab (2016) 0.77
Opioid receptor blockade prevents exercise-associated autonomic failure in humans. Diabetes (2012) 0.77
Estradiol impairs hypothalamic molecular responses to hypoglycemia. Brain Res (2009) 0.77
Maintained expression of genes associated with metabolism in the ventromedial hypothalamic nucleus despite development of leptin resistance during pregnancy in the rat. Physiol Rep (2013) 0.76
Metabolic mystery: aging, obesity, diabetes, and the ventromedial hypothalamus. Trends Endocrinol Metab (2013) 0.76
Brain Glucose Metabolism Controls Hepatic Glucose and Lipid Production. Cellscience (2007) 0.76
Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis. J Clin Invest (2016) 0.76
Magnitude of exercise-induced β-endorphin response is associated with subsequent development of altered hypoglycemia counterregulation. J Clin Endocrinol Metab (2011) 0.76
Brain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studies. Cell Mol Life Sci (2015) 0.76
Hypoglycemia activates arousal-related neurons and increases wake time in adult rats. Physiol Behav (2007) 0.76
Hypothalamic regulation of glucose-stimulated insulin secretion. Diabetes (2012) 0.76
Hypothalamic ventromedial COUP-TFII protects against hypoglycemia-associated autonomic failure. Proc Natl Acad Sci U S A (2013) 0.75
Neuroinflammatory and autonomic mechanisms in diabetes and hypertension. Am J Physiol Endocrinol Metab (2016) 0.75
Proxyfan acts as a neutral antagonist of histamine H3 receptors in the feeding-related hypothalamic ventromedial nucleus. Br J Pharmacol (2012) 0.75
Review of the neuroanatomic landscape implicated in glucose sensing and regulation of nutrient signaling: immunophenotypic localization of diabetes gene Tcf7l2 in the developing murine brain. J Chem Neuroanat (2012) 0.75
Insights into the role of neuronal glucokinase. Am J Physiol Endocrinol Metab (2016) 0.75
Rapid-onset hypoglycemia suppresses Fos expression in discrete parts of the ventromedial nucleus of the hypothalamus. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
Steroidogenic Factor 1 in the Ventromedial Nucleus of the Hypothalamus Regulates Age-Dependent Obesity. PLoS One (2016) 0.75
Leptin acts in the brain to influence hypoglycemic counterregulation: disparate effects of acute and recurrent hypoglycemia on glucagon release. Am J Physiol Endocrinol Metab (2015) 0.75
Ventromedial hypothalamic glucose sensing and glucose homeostasis vary throughout the estrous cycle. Physiol Behav (2016) 0.75
Non-Neuronal Cells in the Hypothalamic Adaptation to Metabolic Signals. Front Endocrinol (Lausanne) (2017) 0.75
Opioid Receptor Activation Impairs Hypoglycemic Counterregulation in Humans. Diabetes (2017) 0.75
How Should We Think About the Role of the Brain in Glucose Homeostasis and Diabetes? Diabetes (2017) 0.75
Impaired Glutamatergic Neurotransmission in the VMH May Contribute to Defective Counterregulation in Recurrently Hypoglycemic Rats. Diabetes (2017) 0.75
Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest (1987) 4.26
Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes (1995) 2.30
Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest (1994) 2.09
ACTIVITY OF SINGLE NEURONS IN THE HYPOTHALAMIC FEEDING CENTERS: EFFECT OF GLUCOSE. Am J Physiol (1964) 1.85
Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes (1989) 1.42
Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog. J Clin Invest (1996) 1.33
Hepatic nerves: a review of their functions and effects. Can J Physiol Pharmacol (1980) 1.29
Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes (1993) 1.28
Hypothalamic control of adrenaline secretion in response to insufficient glucose. J Physiol (1970) 1.16
Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia. Proc Natl Acad Sci U S A (1994) 1.15
Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest (1995) 1.13
Importance of hepatic glucoreceptors in sympathoadrenal response to hypoglycemia. Diabetes (1991) 1.12
The role of liver glucosensors in the integrated sympathetic response induced by deep hypoglycemia in dogs. Diabetes (1994) 1.00
Central nervous system-mediated stimulation of glucagon secretion in the dog following 2-deoxyglucose. Metabolism (1976) 0.98
Glycemic responses induced by hypothalamic stimulation. Neuroendocrinology (1979) 0.91
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science (2001) 11.22
Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med (1999) 8.32
Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia (1999) 8.17
Disruption of IRS-2 causes type 2 diabetes in mice. Nature (1998) 7.94
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell (2000) 7.26
Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes (1999) 7.14
Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest (1999) 6.73
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature (2001) 6.70
Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest (1996) 6.50
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A (2001) 5.48
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest (2002) 5.31
Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell (2001) 5.13
Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes (2000) 4.80
Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74
Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol (2000) 4.64
Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med (1998) 4.40
Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care (2001) 4.30
Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest (1987) 4.26
Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med (1986) 3.90
Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem (2000) 3.90
Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest (1992) 3.55
Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am J Physiol Endocrinol Metab (2001) 3.45
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest (2000) 3.41
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 3.41
Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest (2001) 3.41
Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr (2000) 3.02
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr (2001) 2.98
A model of the kinetics of insulin in man. J Clin Invest (1974) 2.97
Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med (1996) 2.92
Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science (1991) 2.92
Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation (1997) 2.80
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A (1999) 2.76
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes (1997) 2.76
Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J Clin Invest (2000) 2.75
Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest (2001) 2.68
Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med (1998) 2.58
Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care (1999) 2.53
31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 2.52
Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol (1999) 2.44
Exaggerated hyperglycemia after a pizza meal in well-controlled diabetes. Diabetes Care (1993) 2.36
Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes (1995) 2.30
Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med (1987) 2.30
Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1995) 2.25
13C/31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes (1998) 2.21
Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science (1999) 2.19
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev (2001) 2.18
Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes (2001) 2.10
Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest (1994) 2.09
Insulin control of glucose metabolism in man: a new kinetic analysis. J Clin Invest (1975) 2.09
Personal and family factors associated with quality of life in adolescents with diabetes. Diabetes Care (1998) 2.02
Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin Invest (2001) 2.01
An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Nature (1989) 1.97
Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem (2000) 1.95
Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest (1987) 1.92
Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes (1988) 1.89
Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes (2000) 1.89
Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med (1979) 1.88
Effect of ketone infusions on amino acid and nitrogen metabolism in man. J Clin Invest (1975) 1.87
Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord (2003) 1.85
Peroral gene therapy of lactose intolerance using an adeno-associated virus vector. Nat Med (1998) 1.79
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest (1998) 1.75
Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol (1999) 1.75
Retracted Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest (1978) 1.73
Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J Clin Invest (1995) 1.65
Effects of caffeine on muscle glycogen utilization and the neuroendocrine axis during exercise. J Clin Endocrinol Metab (2000) 1.65
Short-term effects of coping skills training as adjunct to intensive therapy in adolescents. Diabetes Care (1998) 1.63
Localized 13C NMR spectroscopy in the human brain of amino acid labeling from D-[1-13C]glucose. J Neurochem (1994) 1.60
Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest (1996) 1.58
Liver glycogen turnover in fed and fasted humans. Am J Physiol (1994) 1.57
Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest (1996) 1.57
Prospective clinical trial of human growth hormone in short children without growth hormone deficiency. J Pediatr (1984) 1.55
Effect of starvation on the turnover and metabolic response to leucine. J Clin Invest (1978) 1.54
Validation of 13C NMR measurement of human skeletal muscle glycogen by direct biochemical assay of needle biopsy samples. Magn Reson Med (1992) 1.51
Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr (1989) 1.51
Somatostatin decreases diarrhea in patients with the short-bowel syndrome. J Clin Gastroenterol (1982) 1.50
In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism. J Biol Chem (2001) 1.49
Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. A 13C nuclear magnetic resonance spectroscopy study. J Clin Invest (1995) 1.47
1H-[13C] NMR measurements of [4-13C]glutamate turnover in human brain. Proc Natl Acad Sci U S A (1992) 1.47
Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J Clin Invest (1989) 1.47
Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. N Engl J Med (1976) 1.46
Direct measurement of brain glucose concentrations in humans by 13C NMR spectroscopy. Proc Natl Acad Sci U S A (1992) 1.46
Clinical and psychosocial factors associated with achievement of treatment goals in adolescents with diabetes mellitus. J Adolesc Health (2001) 1.46
Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia. J Clin Invest (1979) 1.46
Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance. J Clin Invest (2001) 1.45
Assessment of mitochondrial energy coupling in vivo by 13C/31P NMR. Proc Natl Acad Sci U S A (2000) 1.44
Temporal patterns of circulating leptin levels in lean and obese adolescents: relationships to insulin, growth hormone, and free fatty acids rhythmicity. J Clin Endocrinol Metab (2001) 1.43
Fat distribution and cardiovascular risk factors in obese adolescent girls: importance of the intraabdominal fat depot. Am J Clin Nutr (1996) 1.41
The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest (1996) 1.41
Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. J Clin Endocrinol Metab (1978) 1.41
Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. J Clin Endocrinol Metab (1981) 1.37